Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2014 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Amortizatization of Intangibles of $3.3 million for Q2 2026, down 43.05% year-over-year from $5.9 million in Q2 2025, and down 45.99% quarter-over-quarter from $6.2 million in Q1 2026.
Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $3.3 million for Q2 2026.
- In Q2 2026, Amortizatization of Intangibles fell 43.05% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at $20.3 million (down 35.73% YoY), while the FY2025 annual figure was $23.7 million, down 37.1% from the prior year.
- Amortizatization of Intangibles for Q2 2026 stood at $3.3 million, down from $6.2 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $9.9 million in Q2 2024, with the low at -$4.2 million in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $6.0 million (2025), against an average of $5.1 million.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles jumped 756.85% in 2023, then tumbled 44.37% in 2025.
- Ionis Pharmaceuticals' Amortizatization of Intangibles stood at $1.7 million in 2022, then jumped by 404.4% to $8.5 million in 2023, then advanced by 11.32% to $9.4 million in 2024, then tumbled by 39.98% to $5.7 million in 2025, then tumbled by 41.06% to $3.3 million in 2026.
- Business Quant data shows IONS's Amortizatization of Intangibles at $3.3 million in Q2 2026, $6.2 million in Q1 2026, and $5.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.34 Mn |
| Jun 30, 2026 | 3.34 Mn |
| Mar 31, 2026 | 6.19 Mn |
| Mar 31, 2026 | 6.19 Mn |
| Dec 31, 2025 | 5.67 Mn |
| Dec 31, 2025 | 5.67 Mn |
| Sep 30, 2025 | 5.09 Mn |
| Sep 30, 2025 | 5.09 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Jun 30, 2025 | 5.87 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Mar 31, 2025 | 7.11 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 9.14 Mn |
| Sep 30, 2024 | 9.14 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Mar 31, 2024 | 9.26 Mn |
| Mar 31, 2024 | 9.26 Mn |